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Abstract 
Innovative strategies have become necessary in the treatment of patients diagnosed with sexually 
transmitted infections (STIs) and their partners due to increasing rates of infection, transmission, 
and reinfection. Expedited Partner Therapy (EPT) is an evidence-based approach for providers to 
improve partner treatment and decrease reinfection rates in patients with certain STIs. However, 
state-based legislation governs practice implementation and EPT remains prohibited in Kentucky 
(KY) despite Centers for Disease Control and Prevention (CDC) endorsement. Delay in policy 
change presents increased risk for reinfection and continued transmission in KY. John Kingdon’s 
Multiple Streams framework (2003) was used to analyze EPT policy in the state of KY as a 
foundational step toward regulation amendment. Advocacy by increasing provider, lobbyist, and 
legislative awareness and support was also completed. Interventions included a poster 
presentation, white paper formulation and distribution, and communication with key legislators. 
Impact was measured through survey collection assessing agreement variables among 80 KY 
advanced practice registered nurses (APRNs). 94% of respondents agreed that EPT is a 
beneficial treatment strategy and 93.7% indicated support in the advancement of EPT policy. 
This project provides the groundwork for future advocacy efforts for EPT legalization in KY.  
 
Keywords:  Expedited partner therapy; sexually transmitted disease; sexually transmitted 
infection; health policy; legislative advocacy; advanced practice registered nurse 
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Expedited Partner Therapy: Advancing Health Policy in Kentucky 
 
The dramatic increase in the incidence of many sexually transmitted infections (STIs) in 
the past decade demands attention from healthcare practice and policy. According to the Centers 
for Disease Control and Prevention (CDC), Chlamydia trachomatis infection continues to be the 
most common notifiable condition in the U.S. National surveillance data reflects over 1.7 million 
reported cases of chlamydia in 2017, accounting for a 6.9% increase over the previous year 
(CDC, 2018a). This rising trend is alarmingly consistent for many STIs, including those caused 
by Neisseria gonorrhoeae and Trichomonas vaginalis (Ault, 2018). The state of Kentucky (KY) 
is not exempt from high STI transmission rates, with a reported 18,286 cases of chlamydia and 
5,812 cases of gonorrhea in 2016 (CDC, 2017). While these infections affect all genders, races, 
and socioeconomic groups in KY, incidence is higher in females, non-Hispanic blacks, and those 
aged 15-24 years (CDC, 2017). Because it is suspected that many more cases go undiagnosed 
and unreported, current medical practice recommends antibiotic therapy for all partners sexually 
exposed to the infected index case, regardless of the diagnostic testing result, in an effort to 
prevent morbidity in the partner(s) and further transmission (Hopson & Opiola McCauley, 2017).  
The related risks for long-term health complications of STI contraction are widely 
established, including the link to pelvic inflammatory disease (PID), chronic abdominal pain, 
human immunodeficiency virus (HIV), reproductive system cancers, epididymitis, and infertility. 
In response to this epidemic and its related health concerns, the Office of Disease Prevention and 
Health Promotion (ODPHP) initiative Healthy People 2020 has made STI prevention a focus in 
the improvement of national public health, with 18 specific goals relating to improved screening 
and prevention processes. This includes the need for providers to “address system-level barriers 
to timely treatment of partners of persons infected with [STIs], including the implementation of 
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expedited partner therapy for the treatment of chlamydial and gonorrheal infections” (ODPHP, 
2017, para. 10). Expedited Partner Therapy (EPT) emerged in 2006 as a CDC-endorsed, 
evidence-based practice to increase treatment for certain STIs in an effort to reduce transmission 
and reinfection rates (CDC, 2006). EPT allows clinicians to provide STI-diagnosed patients with 
medication or a prescription to deliver to their partner(s) as treatment for exposure. This 
eliminates the requirement for in-person medical evaluation of the partner and expedites the 
treatment process. In contrast, standard practice has relied on either the patient or the provider to 
notify the partner(s) of their exposure to disease and initiate an office visit for treatment. This 
standard has been inadequate in preventing spread of infection. The CDC reports that studied 
health departments made attempts to contact only 12-17% of partners for patients diagnosed with 
chlamydia and/or gonorrhea (2006). Evidence from multiple studies has shown that EPT is an 
effective and beneficial strategy option for those patients with limited access to care or those 
who are at risk for loss to follow up (CDC, 2006).  
Due to the unconventional practice of treating individuals without a physical 
examination, utilization of EPT is governed by individual, state-based regulations. Those states 
with large, urban populations became the first to adopt the practice in order to maximize 
treatment for exposed partners with limited access to healthcare. Since CDC endorsement, nearly 
all states have updated their policies to authorize provider use of EPT in the clinical setting. 
While it is currently legal and utilized in 48 states, EPT remains prohibited in KY (illustrated in 
Figure 1) (CDC, 2018b). Delay in policy change poses a concern for continued spread of 
infection in at-risk KY populations as partners of patients with diagnosed STIs remain untreated. 
Those with low socioeconomic status, low health literacy, and decreased access to healthcare are 
disproportionately at risk for complications related to STIs, making this a clear issue of health 
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equity (CDC, 2015). When evaluating strategies for decreasing transmission, EPT addresses 
these factors by increasing treatment availability, decreasing cost to both the state healthcare 
system and the patient, and addressing personal behavior by mitigating risk for reinfection. The 
lack of EPT legalization in KY state policy can be attributed to many internal and external 
factors. All causative elements in this setting are important to address as delay in policy change 
poses a concern for continued spread of infection in at-risk populations in KY as partners of 
patients with diagnosed STIs continue to remain untreated. 
 
Figure 1. State-based legal status of Expedited Partner Therapy.  
Purpose 
In light of the above-identified findings, the purpose of this project was to analyze the 
current legislative environment for EPT and advocate for the advancement of EPT in KY. For 
EPT to be integrated as a legal practice, the current prohibitory KY state Department of Public 
Health (DPH) regulation “902 KAR 2:080. Sexually transmitted diseases” would need to be 
amended (Kentucky Legislative Research Committee, 2007). The specific aim of this project was 
to provide the groundwork for future advocacy efforts for EPT legalization in KY. 
Literature Review 
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A three-purpose strategy was utilized in reviewing the current evidence supporting a 
policy change for EPT in KY. Evaluation included efficacy of EPT itself, as well as current 
provider knowledge and implementation in states where the practice is legal and utilized. 
Reviewed publications encompassed the original randomized controlled trials (RCTs) which 
evaluated EPT as an evidence-based strategy in clinical practice. An initial entry revealed a total 
of 308 potentially pertinent articles. Quantitative studies were preferred in literature evaluation, 
though several qualitative studies were included for their specific and comprehensive insight into 
the topic area.  
After further quality assessment, which refined index terms and limited research study 
inclusion to those which were published and peer-reviewed, a final pool of 18 literary sources 
was selected for review. This pool included one systematic review, 14 quantitative and 
qualitative studies, one professional committee opinion report, and two national and state-level 
practice guidelines. The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) rating scale 
was utilized to evaluate the strength and quality of evidence in the literature. Evidence descends 
in rating (I-V) from experimental study/RCT or meta-analysis of RCT (level I), through opinions 
of individual experts based on non-research evidence (level V) (Dang & Dearholt, 2018). For 
this review, levels of evidence ranged from I to V, with the majority of studies being categorized 
as level II (quasi-experimental studies) and level III (nonexperimental studies). A hierarchal 
table of evidence of included studies was constructed to portray evidence (Appendix A). 
Practice Efficacy 
Official guidelines on EPT practice were released by the CDC in 2006 after results from 
several RCTs showed increased antibiotic delivery along with equivalent or decreased 
reinfection rates of chlamydia and gonorrhea for patients and their partners (Schillinger et al., 
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2003). In a study by Golden et al. (2005), 2,751 subjects diagnosed with chlamydia and/or 
gonorrhea were randomly allocated into EPT (N = 931) or standard partner management (N = 
929) to determine impact on recurrent infection. A lower rate of recurrence was found in the EPT 
group for both chlamydia (OR 0.82, 95% CI 0.62-1.07, p = 0.17) and gonorrhea (OR 0.32, 95% 
CI 0.13-0.77, p <0.01). In a systematic review by Trelle, Shang, Nartey, Cassell, and Low 
(2007), the efficacy of partner notification was evaluated. EPT (defined as Patient-Delivered 
Partner Therapy [PDPT] in this study) was appraised as a method of improvement in patient 
referral and reinfection rates. Five of the six trials reflected a reduced risk of persistent or 
recurrent infection in patients with chlamydia or gonorrhea in the PDPT intervention group 
(summary risk ratio 0.73, 95% confidence interval 0.57 to 0.93) (Trelle et al., 2007). RCTs 
which evaluated EPT had strength in large sample sizes and achieved statistical power. Presence 
of infection was assessed using valid laboratory urine and swab culture testing which have high 
reliability rates (Trelle et al., 2007). However, loss to follow up may have affected internal 
reliability and EPT adherence measures were subject to patient report.  
Provider Knowledge 
 Corresponding themes emerged from reviewing literature pertaining to provider 
knowledge, attitudes, and implementation in practice. Provider knowledge impacts 
implementation of EPT as a treatment strategy. Several different medical specialties were 
evaluated, including family practice, gynecology, pediatrics, medical directors, and pharmacy. 
Methods for assessing knowledge were generally survey or interview-based, cross-sectional 
designs which used random or purposeful sampling techniques (Rosenfeld et al., 2015; Lee et al., 
2014). In one review, only 20% of surveyed providers (n = 195) reported a history of using EPT, 
and the majority of this sample group were unaware of or misguided on the legal status of the 
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practice in their state (Lee et al., 2014). Even in samples reporting familiarity with the therapy, 
providers often mislabeled or misinterpreted the definition of EPT along with its scope and uses 
(Hsii, Hillard, Yen, & Golden, 2012; Introcaso et al., 2013; Lee et al., 2014). Studies showed 
EPT was not a strategy discussed routinely in formal didactic courses, which may partially 
account for the lack of knowledge surrounding the practice. Providers reported the majority of 
knowledge on this topic was gained from continuing education, conferences, or direct patient 
care with faculty preceptor (Hsii et al., 2012; Rosenfeld et al., 2015). When knowledgeable on 
the practice, the majority of providers participating in EPT report favorability towards the 
treatment strategy and agree the therapy has extended public health benefits (Hsii et al., 2012; 
Golden et al., 2015). 
Policy in Implementation 
 Policy was a central theme in the assessment of EPT practice, and all studies found a 
general lack of provider and administrator fluency in both state and facility-based policies 
regarding the use of EPT (Hsii et al. 2012; Introcaso et al., 2013; Rosenfeld et al., 2015). Lack of 
regulations endorsing EPT as a treatment practice is the most commonly cited barrier in the 
literature (Hodge, Pulver, Hogben, Bhattacharya, & Brown, 2008). Alternatively, research has 
associated a formal written policy permitting EPT with a higher rate of provider use (Hodge et 
al., 2008; Hsii et al., 2012; Owusu-Edusei Jr. et al., 2017). Providers who practiced in an 
organization where facility protocols included EPT as a treatment option were more likely to 
implement the therapy in their practice (Schillinger, Gorwitz, Rietmeijer, & Golden, 2016). 
These findings reflect a need for updated and explicit state health policy to support the successful 
implementation of EPT.  
Theoretical Framework 
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 A theoretical framework which concentrates on political ideology and policy formulation 
was selected to promote a legislative analysis and advocacy design. Originally introduced in 
Kingdon’s 1984 published work Agendas, Alternatives and Public Policies, the Multiple Streams 
framework provides a means of understanding public policy and agenda setting by examination 
of historical processes in the United States’ political system (Kingdon, 2003). The framework 
identifies three categories of variables which work both independently and interpedently to 
determine agenda setting and policy advancement. These categories (deemed “streams” by the 
author) are further delineated as the problem, political, and policy streams (illustrated in Figure 
2). The confluence of these streams interacts to produce “windows of opportunity” for legislative 
action (Kingdon, 2003). The Multiple Streams framework was utilized in this project to conduct 
the following legislative analysis, which involved the evaluation of each framework variable in 
the context of the KY policy arena. Through analysis, it was determined that timing, value 
acceptability, administration changes, and lobbyist involvement may be the largest weighted 
factors in future EPT integration for the state of KY. Additionally, barriers to past proposal 
attempts were identified along with possible facilitators to future agenda advancement. This was 
done in order to fully assess the current climate of KY legislature and to determine a direction of 
action for advocacy efforts. 
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Figure 2. John Kingdon’s Multiple Streams framework  
Problem Stream 
 The problem stream contains all variables which determine how and when legislators and 
policy makers learn about adverse conditions and how such conditions become defined as a 
political problem (Kingdon, 2003). While adverse conditions are abundant in everyday life, they 
only become political problems when people believe they should take action to change them. 
Establishment of a political problem is the first step in promoting practice and policy change. 
This is accomplished via the analysis of four problem stream variables: indicators, focusing 
events, feedback, and load. 
 Indicators. Floating at the beginning of the problem stream are indicators, which are 
used to assess the magnitude and status of a condition. Large magnitude and deteriorating status 
of a condition helps to establish it as a political problem to both officials and the public 
(Kingdon, 2003). In the health policy realm, indicators include prevalence, incidence, and 
healthcare cost. STI prevalence and incidence have consistently increased in the U.S. over the 
past decade. This national incline is mirrored in the state of KY, where the incidence rate of 
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chlamydia has more than doubled in the last 10 years (CDC, 2017). The prevalence and 
transmission of STIs carry a heavy economic burden. According to a CDC-sponsored study, the 
total lifetime direct medical cost of the 19.7 million STI cases in 2008 was $15.6 billion (Owusu-
Edusei et al., 2013). Among non-viral STIs, Chlamydia was the costliest infection at $516.7 
million, followed by Gonorrhea at $162.1 million (Owusu-Edusei et al., 2013). These estimates 
do not include indirect costs (e.g., loss of productivity) or intangible costs (e.g., pain, suffering, 
and infertility) associated with many STIs. These statistics serve as indicators that STIs are a 
major problem in the state of KY, and the increasing incidence in the last year is a marker for 
negative status change.   
 Focusing events. Disasters, crises, personal experiences, or powerful symbols are termed 
as focusing events along the problem stream. While indicators may establish a political problem, 
the data themselves are not always self-evident enough to launch an agenda campaign. Focusing 
events become an extra push that brings an issue to the attention of policy makers, while a lack 
of crisis may leave potential agenda items overlooked (Kingdon, 2003). Often times, a personal 
experience or story becomes the face of a policy campaign in efforts to humanize an agenda and 
make it memorable to legislators and the public. While indicators show that STI transmission 
affects many people, the general stigma and privacy associated with diagnosis becomes a barrier 
in finding a personal experience to represent a campaign.  
 Lack of a perceived disaster or crisis can also be considered a factor in the delay to EPT 
policy formulation in KY. However, public health crises for STI transmission are looming on the 
horizon for the US and KY alike. These crises are expected to develop due to increasing bacterial 
resistance and inadequate coverage of current antibiotic regimens. Antibiotic resistance is 
already a concern for gonorrheal infections, and care standards now recommend dual therapy of 
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ceftriaxone injection plus oral antibiotic therapy to ensure cure (CDC, 2015). According to 
providers at the Louisville Specialty Clinic, a branch of the Louisville Metro Department of 
Public Health & Wellness which focuses on STI screening and treatment, cases of resistant 
trichomoniasis are also emerging. These clinicians attribute increasing bacterial resistance to two 
factors: failure to complete antibiotic therapy and reinfection (V. Hughes, personal 
communication, September 27, 2018). Reinfection most commonly occurs when a treated patient 
continues to have sexual relations with a partner who has not received antibiotics. While the 
indicators clearly show a problem in STI transmission and bacterial resistance alike, no crises or 
“epidemics” have been publicized to create a focusing event for legislative action in KY.  
 Feedback. Another variable afloat in the problem stream is feedback, which refers to the 
way a problem or promoted policy change is brought to the attention of decisionmakers. 
Feedback can be formal or informal. Routine monitoring of costs through budgeting and 
government-sponsored program studies is considered formal feedback. In contrast, informal 
feedback is provided to a legislator by their constituents in the form of streams of complaints 
about a condition, or support or opposition of a specific bill being proposed. Chlamydia and 
gonorrhea cases are mandated to be reported to the state department of public health for 
epidemiologic and budgeting purposes (CDC, 2006). However, this formal reporting is subject to 
review in the public health domain and it is not regularly addressed in the legislative realm. 
Informal feedback in regard to STI transmission has also not been consistently presented to 
policy makers. While there is no available research to indicate a reasoning behind the lack of 
citizen feedback, one could hypothesize that this is due to the sensitive nature and social stigma 
that come with transmission of these infections. Additionally, patients may not be aware to lobby 
for additional treatment strategies unless they are educated by their providers on these practices.  
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Providers must be advocates for their patients in providing feedback to officials and advancing 
health policy. 
 Load. The problem load must be considered when presenting an issue to the policy 
agenda. Even though indicators may point to a problem, legislators may be inundated with topics 
to tackle in any given session. In KY, annual legislative sessions vary in length depending on the 
year. Even years contain a full 60 legislative days, whereas odd years are “short sessions” and 
only have 30 legislative days. Odd years (such as this most recent 2019 session) often experience 
an increased problem load due to lack of legislative time. Consequently, a specific issue may fall 
in priority or the topic may get left off the agenda entirely.  
Lobbyists have increased campaign success if they accommodate their ideas to the 
current problem load. The KY Department of Public Health (DPH) released the Kentucky State 
Health Improvement Plan 2017-2022, which outlines what the department considers the most 
pressing issues for the state during the next five years. This improvement plan uses a health 
equity framework to highlight substance abuse disorder, smoking, obesity, adverse childhood 
experiences, and integration to health access. Integration to health access is defined by this team 
as ensuring “all Kentuckians have access to integrated medical, dental, behavioral, and social 
services to improve and maintain their health through the development of coordinated, multi-
disciplinary systems of care” (KY DPH, 2017, p. 53). Healthcare access is specifically linked to 
infectious disease in the health equity framework. Using this definition, EPT aligns with KY’s 
current aims for health promotion by targeting exposure to infectious disease and halting the 
transmission process. EPT should be presented to KY legislation as a policy that aligns with the 
current health improvement plan for the state. Accommodating EPT into the current problem 
load can provide focus in legislature for this particular issue to increase priority in action.  
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Political Stream 
 The political stream is a separate entity running alongside the problem stream. It contains 
all variables to be considered in measuring legislative support for an agenda, which is a major 
factor in determining the potential success of a policy. The variables addressed in this branch 
include the national mood, organized political forces, and administration changes. These move 
from public to governmental factors, and encompass pressure group forces, electoral, and 
partisan influences. Public policy is intertwined with political events as shifts of key players (i.e. 
new legislators and cabinet, board, and team members) influence agenda setting.  
 National mood. While some variables in the political stream are tangible in government 
schematics, the national mood is a less concrete force subtly directing the policy agenda. 
Kingdon describes this mood as a national climate subject to broad social movements and 
general changes in public opinion (2003). The national mood directs what the public may or may 
not prioritize, be concerned about, or work to address. Themes in this variable can be apparent in 
media and social avenues. However, public opinion is often labile depending on the current 
societal events and conditions. Legislators’ perception of the national climate can serve either as 
a propelling or constraining force in agenda topics. The lack of a public campaign for decreasing 
STI transmission has served as a constraining force for EPT treatment legislation. The overall 
mood will need to be favorable toward public health, sexual health, and EPT in order for a 
regulation amendment to be successful in the state.  
 Organized political forces. Governmental agendas can be defined as general or 
specialized. General agendas usually refer to those promoted by the president to purse a broad 
national direction. Specialized agendas are often driven by special interest groups, including 
lobbyists, dedicated government departments, and boards or committees of experts. In the 
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political stream, mobilization of health-related agendas is often driven by specialized organized 
forces. These organizations must perceive a benefit for their respective platforms in order to be 
influential advocates. The ODPHP and KY DPH can both be considered dedicated departments 
to public health and disease prevention. However, the concept of jurisdiction is important to 
consider in targeting useful political forces for KY health policy advancement. While the 
ODPHP highlights EPT as a strategy in achieving “timely treatment” for partners, their national 
jurisdiction limits the influence in individual state legislation (2017, para. 10). The KY DPH is a 
driving force for health policy advancement for the state. Along with aligning agenda items with 
current DPH goals, as was done when considering the problem load, gaining support from 
individual leaders in this department may open policy advancement opportunities.  
 Lobbyist groups are also major influencers of the policy agenda. These groups are often 
formulated from professionals and experts in a field who collaborate under an organizational 
mantel to promote their ideas to legislators. Lobbyists play a large role in education and 
campaign organization, providing a united front for a body of individuals and attaching a face 
and name to many policy advancement propositions. The KY Board of Medicine (KBM) and KY 
Board of Nursing (KBN) can be considered two organized political forces that influence 
healthcare in KY. The Kentucky Association for Nurse Practitioners and Nurse-Midwives 
(KANPNM) is another prominent lobbyist group in the state’s health policy arena. The 
association’s mission is to “empower KY Advanced Practice Registered Nurses in providing 
quality, accessible and compassionate healthcare through education, leadership and advocacy” 
(KANPNM, 2018, para. 1). This group acts a political force in KY by advocating for policy 
advancements in clinical practice change, patient care, and diagnostic and prescribing rights for 
Advanced Practice Registered Nurses (APRNs). Dr. Beth Partin, the Legislative Committee 
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Chair for the KANPNM, was consulted to determine the coalition’s current capacity to promote 
EPT regulation for the 2019 legislative session. The KANPNM spent the majority of its 2019 
legislative energy on advocating increased prescriptive authority for APRNs and was unable to 
take on EPT as an issue during this year’s session. However, Dr. Partin indicated that the 
addition of EPT as a KANPNM agenda item would be feasible in the future if a legislator 
sponsor were to be found (personal communication, August 8, 2018). As a voice in the state 
legislative arena, the KANPNM was a target group in this project for increasing provider and 
lobbyist awareness and support of EPT policy in KY.  
 Administration changes. The last variable in the political stream is administration 
changes. These changes occur due to term limits, elections, and the balance of partisan 
majorities. Turnover of key personnel brings agenda and goal changes according to the priorities 
and values of the new incumbents. Election terms apply to members of the House of 
Representatives and the Senate. Representatives serve two-year terms and are considered for 
reelection every even year. Senators hold six-year terms and elections are staggered so that only 
about one-third of the Senate is up for reelection during any given year. However, neither 
representatives nor senators are subject to term limits, meaning that each member may serve an 
unlimited number of terms as long as they are reelected to the position. Representatives are most 
directly responsible for presenting new health policy to the state house for approval and a 
sponsor is needed for committee formulation and bill proposal. An eventual 2/5th approval by the 
members of the chamber is needed for bill approval. If a bill passes one chamber it is then sent to 
the other for approval, and both bodies must agree on the final form for it to become a state 
statue or regulation. 
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 While administration changes provoke new topics of discussion, they may make 
deserving items impossible to consider. In both 2014 and 2015, regulation amendment legalizing 
EPT was proposed to the KY House of Representatives by Representative Mary Lou Marizan. 
As a former registered nurse, Rep. Marzian (D) has served as an advocate for public health 
policy in the KY House. However, both attempts at proposing an EPT regulation did not pass to 
final vote. Legislature influence should be considered in this failure, as these bills were cast to a 
predominantly republican House with a socially conservative and fiscal agenda. As a political 
stream variable, administration changes play one of the largest roles in determining policy 
success and failure, and it is likely that partisan influences had a negative impact on the success 
of these bills. Today, administration party ratios remain a factor to consider in policy 
advancement as the current voting majority in the KY House has been retained by Republican 
constituents, with a 61% (R) / 39% (D) voting share. Consequently, the climate of both the state 
House and Senate becomes integral in the proposal and success of EPT policy. 
Policy Stream 
 The final stream in this framework is the policy stream. Kingdon describes the policy 
stream as both a flow of “natural selection” and a relative “primeval soup” where ideas swirl and 
circulate in policy communities until action is attached to them (2003, p. 116-117). Communities 
in this sense describe the collection of specialists and experts in a given policy arena. Ideas in 
this stream follow a seemingly erratic path in their progression towards action. Some become 
prominent for a time and then fade as other ideas take their place. Other times, an idea will 
evolve as it meshes with another concept and combines in various ways. Kingdon acknowledges 
a generally long process of “softening up” the public and legislature before an agenda gains 
momentum towards policy change (2003). In this softening stage, ideas must be floated, 
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proposals drafted, and then amendments made in a response to public or legislator reactions. 
Furthermore, in order for this “soup of ideas” to evolve into a tangible policy agenda, 
communities must consider three separate policy stream factors: timing for exploitation, 
technical feasibility, and value acceptability. 
 Timing for exploitation. As ideas stir in the policy stream, timing becomes an integral 
factor attributing to a proposal’s success or failure. As previously discussed, factors in both the 
problem stream and the political stream influence the way issues are perceived and prioritized in 
the policy agenda. While problems may exist in a community, timing affects the order in which 
they are addressed. Often, lobbyists and policy makers must play a waiting game for an opening 
in the political realm where they can insert their proposal. Optimal policy timing balances a 
trade-off between delaying reforms and implementing immediate action plans. Using this cost-
benefit approach, policy makers weigh the potential social or health burden of delaying policy 
versus the risk of failure which can occur with immediate action but poor political timing.  
 Benefits to delaying agendas include additional time to collect better data, as well as the 
possibility of capturing a more receptive audience due to national climate changes. Though a 
policy may be structurally sound, if the timing does not allow adequate attention and support to 
be garnered, it will fail to pass through legislation. Kingdon addresses the importance of 
preparation in the policy stream, emphasizing that a “proposal must be worked out beforehand, 
and must surface and be pushed when the window is open” (2003, p. 172). Timing for 
exploitation can be seen as barrier for past EPT implementation attempts. However, having prior 
preparation for EPT legislation in KY is a facilitator for future policy development. The KY 
House of Representatives will begin a new session in January of 2020. As new committees and 
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agendas emerge in this session, opportune timing will be necessary to bring EPT back to the 
forefront of legislation.  
 Technical feasibility. The second variable along the policy stream addresses technical 
feasibility of reform, including policy formulation, campaign efforts, and clinical 
implementation. The problem load for both legislation and lobbyist forces becomes an 
interdependent factor in assessing technical feasibility. Lobbyists achieve more success when 
focusing on one or two issues at a time depending on the workload necessary to drive political 
change. This workload differs depending on whether a specific agenda requires a statue or a 
regulation change. Both statutes and regulations have the force of law. The term “statute” refers 
to a law enacted by a legislative body of a government, whether at the federal or state level. 
Statutes are generally broad in their scope and provide a framework for more specific 
regulations. Regulations are created by governmental agencies, often to actually implement a 
given statue. Most regulations are developed through a process which includes public input, 
allowing citizens to influence and shape their laws directly. In general, regulations are easier to 
amend than statutes because they often require a simple amendment to update practice instead of 
a statutory repeal (Mason, Gardner, Outlaw, & Grady, 2016). In the case of EPT, the prohibitory 
law in KY is a DPH regulation, which should facilitate an easier process of amendment.  
 Clinical implementation is also a consideration as EPT is brought to the agenda. Policy 
makers want to ensure that a program will work in application before it is approved. 
Implementation of EPT in the clinical setting has been researched in states where the practice is 
utilized. While prohibitory legal status has been noted as a barrier, studies have correlated formal 
written policy permitting EPT as an effective implementation strategy associated with a higher 
rate of provider use (Hodge et al., 2008; Schillinger et al., 2016). Additionally, EPT has been 
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linked to lower societal and health care costs as compared to the standard treatment of patient or 
provider-based referral (Gift et al., 2011; Hopson & Opiola McCauley, 2017). These findings 
indicate the therapy as a clinically feasible and cost-effective option for provider use.  
 Technical feasibility has also been demonstrated by the number of states which have 
adopted EPT policy into regulation since CDC endorsement in 2006. As of 2018, policy 
expressly permitting EPT use has been successfully developed and implemented in 42 states and 
the District of Columbia. Six other states have repealed legal barriers to implementing EPT but 
have not yet explicitly defined the practice in their state regulations (CDC, 2018b). To aid in the 
adoption EPT state health policies, Arizona State University (2011) partnered with the CDC in 
publishing a toolkit to educate on legislative language, liability issues, and considerations for 
drafting legislation and regulations. This model kit serves to enhance technically feasibility in 
legislative adoption of EPT policy.  
 Value acceptability. Value acceptability transcends standard liberal-conservative 
dimensions and incorporates the concepts of equity, efficacy, and moral ideology. Tailoring a 
proposal to meet an audience’s values greatly affects the reception of the idea. While focusing on 
scientific data such as epidemiology and public health benefits may enhance EPT’s appeal in the 
community of medical professionals, this strategy is less likely to leave a lasting impression on 
legislators and policy makers. Highlighting values of cost reduction and state health 
improvement may produce better results in the legislative arena. Value acceptability takes on a 
slightly different interpretation when considering EPT in the public eye due to the differing 
moral ideologies that are held surrounding sexual behavior and sexually transmitted disease. As a 
whole, open discussion surrounding sexual practices has remained taboo in modern society 
which hinders public understanding and sense of urgency in addressing the STI crisis. In 
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consideration of the impact value acceptability takes on policy advancement, this project aimed 
to increase education and facilitate frank and comprehensive dialogue about the STI crisis, 
sexual health, and treatment strategies to state legislators.  
Policy Window 
 As variables in the agenda setting streams move forward toward policy formulation, a 
window of opportunity is opened. While the problem, political, and policy stream run separately, 
they intertwine and couple at critical times to provide opportunity for change. This opening 
allows for policy advocates to bring attention to their problem and push their ideas and solutions 
toward written regulation. Policy windows open only occasionally and the timeframe in which 
they stay open may be quite brief. Policy entrepreneurs and advocates promoting specific 
agendas must act rapidly before the opportunity passes by. Otherwise, they may have to wait on 
their solutions until the next window comes along. In some instances, the window opens in a 
predictable fashion, as when a meeting is scheduled for annual revision of a policy. However, the 
policy window is not quite as easily projected in the case of EPT. Due to this unpredictability, 
Kingdon writes that it is important to policy entrepreneurs to be prepared, with their problem 
well-documented and their proposed solution ready in waiting for the opportune window to 
advance their agenda (2003, p. 165). As EPT advocates await a window of opportunity for 
regulation amendment in KY, foundational interventions were selected to increase knowledge of 
EPT and support for policy and practice change in order to improve chances for future legislative 
success.  
Setting and Organizational Assessment 
With a mix of provider and lobbyist influence in the state legislative arena, the 
KANPNM was selected as the main audience for interventions which addressed providers. This 
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association is composed of approximately 2,000 KY APRNs and graduate nursing students. 
Additionally, ten legislators were selected as target contacts for legislature awareness 
interventions. Known barriers to change for both lobbyist and political audiences include heavy 
problem load, as many state healthcare concerns are continually being brought to the attention of 
policy makers and advocates. Additional known barriers to change for legislator audiences 
include value acceptability and perception of technical feasibility in the integration of EPT into 
state regulation. 
Intervention 
This project was composed of four grassroots EPT advocacy interventions. A logic model 
was formulated to demonstrate project advocacy activities and consequent goals (Appendix B). 
The first intervention, targeted towards providers and lobbyists, included a poster presentation 
titled “Expedited Partner Therapy for Treatment of STIs: Advancing Health Policy in 
Kentucky”. This literature review poster was presented by the project lead at the annual 
KANPNM conference in Lexington, KY in April 2018. The poster educated KY APRNs and 
association lobbyists on EPT and current legality, as well as provider use, knowledge, and 
facilitators for implementation in states where it is allowable (CDC, 2018c). This was done as a 
foundation for further advocacy efforts through the KANPNM.  
The second intervention was the authoring and distribution of a white paper, which 
stemmed from the CDC 2015 sexually transmitted diseases treatment guidelines, and highlighted 
EPT efficacy, implementation, and policy advancement. The formulation of this document 
utilized the problem stream variables of indicators and focusing events to demonstrate the need 
for policy change while aiming to increase value acceptability to readers. The white paper was 
distributed through email to APRNs and by mail to select legislators. The third intervention was 
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survey administration and collection from APRNs to measure participation, EPT knowledge, and 
intent to support. This project was submitted to the university Institutional Review Board prior to 
implementation and was deemed exempt from full review as it did not meet research criteria.  
The fourth intervention was legislator contact to increase EPT awareness and support. 
Legislator participants were selected by the project lead and recruited through mailed white 
paper submission along with follow-up email and phone contact attempts. Six KY House 
Representatives and four KY Senators were chosen due to their projected receptivity to health 
policy advancement as well as their region of influence. Legislators from the counties with the 
top three chlamydia incidence rates were selected: Union, Jefferson, and Fayette (CDC, 2017). 
Legislators were active members of their respective chambers to be included. Seven legislators 
were able to be contacted via phone call or email. These contacts indicated agreement that STI 
transmission is a concerning problem in KY and should be a priority topic for the state to tackle 
in upcoming legislative sessions. Six of the contacts stated they were unaware of EPT practice 
and indications prior to project education efforts, including its current illegal status in KY. All 
seven contacted legislators indicated that they would support EPT legislation and its integration 
should it be introduced as a bill in upcoming sessions. 
APRN Survey Administration and Results 
Participants. Participants included KANPNM members and KY legislators. For poster 
presentation, participants were KANPNM conference attendees. For survey collection, 
KANPNM members were invited to complete an anonymous survey through an email invitation 
with preamble consent prior to survey access. Clicking “proceed” after preamble review 
indicated informed consent for participation. All participants were members of the KANPNM to 
meet inclusion criteria. Members who were graduate students and those APRNs not currently 
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practicing (in education and administrative roles) also met inclusion criteria due to their 
stakeholder status. 
Data Collection. Data was collected through responses to a secure, encrypted 
Surveymonkey account. The link to this survey was administered through an approved 
KANPNM listserv, ensuring all participants were eligible for inclusion. Ethical considerations 
included value acceptability and current practice strategies among participants. Questions were 
structured to be inclusive and avoid ethical dilemmas, allowing participants to skip questions, 
answer “not applicable” in demographic variables, and “neither agree nor disagree” in agreement 
variables when applicable. Responses were anonymous and no identifiers were collected. 
Surveys were downloaded from a secure server and stored on an encrypted computer as well as a 
password protected USB drive. 
Measurement. Project impact was assessed through KANPNM member survey 
responses. Demographic variables were collected, including education level, years of experience, 
and current practice status in KY and with patients diagnosed with STIs. Participants were also 
asked to answer a six question, five-point Likert scale assessment. This scale was selected due to 
its validity in quantifying and measuring agreement indicators. Questions measured perception of 
EPT knowledge, satisfaction with standard practice, EPT efficacy, and likelihood in partnering 
for future advocacy efforts.  
Results. Results of the APRN survey were evaluated using descriptive statistics. A total 
of 80 (n = 80) participants responded to survey invitation. No responses were excluded. 
Demographic variables indicated a mix of provider experience, education, and current practice 
status (see Table 1). 71.25% of respondents were currently practicing in KY. Years of experience 
varied, with most respondents falling into either the “1-5 years” or the “15+ years” categories 
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(illustrated in Figure 3). 83.5% (n = 66) of participants held a master’s or doctoral degree in 
nursing. 65.34% (n = 51) of participants indicated that they practiced in a setting where they 
encounter patients for STI diagnosis and treatment.  
 
Figure 3. Respondent years of experience with corresponding distribution 
One participant completed only demographic variables, and therefore Likert-scale 
questions were evaluated out of the 79 respondents who completed the survey (illustrated in 
Figure 4). Agreement variables were assigned the following numerical values for statistical 
analysis: Strongly disagree (1), Disagree (2), Neither Agree nor Disagree (3), Agree (4), and 
Strongly Agree (5). Both “Agree” and “Strongly Agree” were considered positive responses. 
Responses reflected overall satisfactory perceived knowledge, with 73.41% (range 1-5, mean: 
3.65, SD: 1) of respondents indicating that they felt knowledgeable of EPT and its indications.  
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Figure 4. KANPNM member responses regarding Expedited Partner Therapy in Kentucky 
Results also demonstrated provider acknowledgement of practice change need for 
partners of STI-diagnosed patients. While 51.9% of providers indicated agreement that current 
practice strategies for STI prevention and treatment were adequate for their patients, 64.55% 
disagreed or strongly disagreed that these same strategies were adequate for partners. The results 
also reflected strong positivity toward EPT and future policy advancement in KY. 92.4% (range 
3-5, mean 4:53, SD: 0.63) of surveyed providers either agreed or strongly agreed that EPT is a 
beneficial treatment strategy for patients and partners. 82.7% (range 2-5, mean: 4.38, SD: 0.86) 
of surveyed providers indicated that they would utilize EPT in their clinical practice if it were 
legalized. Finally, 93.7% (range 2-5, mean: 4.61, SD: 0.68) of surveyed providers indicated they 
would support EPT policy advancement in KY. 
Policy Analysis Outcomes and Discussion 
Results from policy analysis and advocacy efforts were measured through qualitative 
evaluation of verbal feedback from providers and legislators. The poster presentation received 
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status in KY, and indication for state regulation amendment. Many APRNs stated that prior to 
project intervention, though they were aware of the high STI incidence rates in the state, they 
were not fully knowledgeable on EPT practice or the significant impact of state regulation on 
provider strategies for STI treatment. These providers indicated they would increase their 
advocacy for future EPT legislation due to project impact. Through follow-up contact with target 
legislators after white paper distribution, feedback was collected from seven representatives and 
senators who all reported favorability toward future EPT advancement in KY. Five legislators 
were unaware of the high STI incidence rates in the state, and reported they were not 
knowledgeable about updated CDC guidelines, EPT practice, and STI state regulation prior to 
education through project interventions. All contacted legislators indicated that increased 
knowledge of high STI incidence and transmission, as well as the impact of state regulation on 
STI treatment options was influential in increasing legislative support of policy amendment. All 
contacted representatives agreed that increased lobbyist and stakeholder advocacy is crucial for 
amendment success and stated they would support the future integration EPT into state health 
policy.  
Interpretation 
Policy advancement requires a balance of many variables; initial legislative analysis 
found that timing, value acceptability, administration changes, and lobbyist involvement may be 
the largest weighted factors in future EPT integration for the state of KY. Responses from 
legislators reflected favorability towards the future integration of EPT in KY state regulation, 
which is a vital component in policy change. A sponsoring legislator will need to be secured for 
bill proposal and future advocates may consider approaching one of the legislators who were 
amenable to such policy change through this project.  
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Survey results reflect that KY APRNs acknowledge the need for updated STI state policy 
and indicate support for the advancement of EPT. As stakeholder support is one of the most 
crucial aspects of agenda success, this project accomplished its goal in advocating for EPT by 
increasing provider and lobbyist support. However, APRNs are not the only stakeholders in the 
healthy policy realm and other specialties such as medical doctors, pharmacists, and public 
health workers should be consulted and targeted for advocacy interventions. Future advocates 
may consider advancing interventions to lobbyist groups such as the KY Board of Nursing, KY 
Board of Medicine, and KY Department of Public Health.  
An incidental finding in this project during verbal feedback indicated that many KY 
providers are currently utilizing EPT in clinical practice without knowledge that it is prohibited 
in the state. This may be to provider migration from other regions, as EPT is taught and regularly 
implemented in most other states in the country. This finding indicates a need for increased 
education to providers on EPT practice and its current regulatory status in KY.   
Limitations 
Several limitations were encountered during project implementation. Survey results were 
limited by small sample size and low response rate. Additionally, due to project scope, 
participants were restricted to those in the nursing field. Increased interdisciplinary sponsorship 
through all healthcare roles will be necessary to dramatically improve the chance of amendment 
success. Generalizable assessment of legislator support was limited due to small sample size and 
similar partisanship of contacts. Partisan influences have limited EPT advancement in past 
attempts and may become apparent in the future if a bill were to be sponsored.  
Progression of a bill for regulation amendment was limited during project 
implementation due to several factors. Firstly, the 2019 KY legislative session was “short”, 
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consisting of only 30 legislative days instead of a full 60 (occurring on even-numbered years). 
This resulted in an increased problem load for lobbyists and legislators as other pressing matters 
for KY state health took precedence over STI transmission. While STI incidence continues to 
increase in KY, the lack of a focusing event such as major STI crisis or perceived epidemic 
continues to be a limitation in policy advancement. Treatment failure due to uncontrolled 
transmission and antibiotic resistance may serve as a future focusing event to move EPT policy 
forward in the state. Additionally, this shorter legislative session limited long-term follow up 
with legislative contacts which may have facilitated agenda advancement. KANPNM lobbyist 
efforts for EPT were restricted due to simultaneous needs for advocacy efforts in APRN 
prescribing authority. An overarching limitation to all policy advancement stems from the multi-
factorial political arena, where advocates must work to balance ever-changing variables in the 
Multiple Streams Framework in order to best predict the opening of a Policy Window. 
Conclusion 
EPT is an evidence-based approach which increases treatment and adherence for partners 
with patients diagnosed with STIs. The lack of DPH regulation amendment supporting EPT in 
KY limits provider options in caring for patients diagnosed with certain STIs. The practice of 
EPT could be a benefit to many patients in the commonwealth; especially for those patients who 
are high-risk and partners who may not have access to health care or choose not to pursue 
physical examination. Therefore, legislation in KY should be updated to include explicit health 
policy allowing EPT use according to CDC recommendations and provider discretion as they 
collaborate with their patients to formulate safe, efficacious treatment plans.  
Both the healthcare and legislative arenas are complex organizations which require 
adaptability to ever-changing environments. In order to advocate for EPT policy advancement in 
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KY, a four-fold intervention was conducted. APRNs are an ideal target audience for poster and 
white paper interventions due to their stakeholder status in KY health policy. APRNs are trained 
to be leaders in their healthcare communities and are influential advocates for policy change in 
the political arena. APRN participants indicated increased awareness and support of EPT 
integration into state policy. Additionally, seven initial legislator contacts were made, and verbal 
feedback indicates positive receptivity towards EPT in the future. These responses indicate an 
achieved goal for this project’s scope of influence.   
State representatives and senators are most directly responsible for presenting new health 
policy to the respective House and Senate for approval. A sponsor will be needed for committee 
formulation and bill proposal. While the next legislative session will not begin until January 
2020, advocates for EPT are needed to raise awareness of STI transmission and therapeutic, 
evidence-based practice alternatives to standard practice inadequacies. The 2020 legislative 
session will last a full 60 legislative days which may mean more opportunity for bill proposal 
and committee delegation towards regulation amendment. Enhancing stakeholder knowledge and 
buy-in, appealing to lobbyist groups for platform support, and engaging in personal and 
meaningful discussion with legislators will continue to be necessary interventions in integrating 
EPT and improving chance of agenda success. Advocates are encouraged to reach out to their 
coalition leaders and legislators to stimulate conversation on EPT and the related need for 
practice change as policy advocates work towards the opening of a window of opportunity for 
STI regulation amendment in KY.  
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Appendix A 








Findings Quality of Evidence 
Trelle et 
al., 2007 
Level I Systematic review of 
RCTs; 
intervention as 
supplement to standard 
patient referral. 
Data sources: 
7 electronic databases 
searched 
January 1990 to 
December 2005  
-Random effects 
meta-analysis: 
14 trials (N = 12,389) 
Subjects with gonorrhea, 
chlamydia, 
urethritis, trichomoniasis,  
EPT specifically: 6,719 
(4,912 women, 1807 men) 
in 6 RCTs 










in index patients 
2)  number of 
partners treated; 
number of partners 
tested or testing 
positive; and 
number of partners 
notified, located, or 
elicited.  
Measures:  
Reinfection rates as 
defined by each 
infection’s gold 




















Cochran’s Q & 
the I2 statistic; 
In meta-
analyses with at 
least 5 trials: 
funnel plots & 
statistical 
testing for small 
study effects.  
1) Meta-analysis of 5 RCT 
linked EPT to reduced risk of 
persistent or recurrent 
infection in patients with 
chlamydia or gonorrhea 
(summary RR 0.73, 95% 
confidence interval 0.57 to 
0.93) 
2)supplementing 
patient referral with 
information for partners also 
effective  
3) 2 RCTs found providing 
index patients with 
chlamydia with sampling kits 
for their partners 
increased # of partners who 
got treated 
4) increase in 
the number of partners treated 
(risk ratio 1.44, 95%, CI 1.12 
to 1.86), but statistical 
heterogeneity high (I2 94%, P 
< 0.0001) 
Strengths:  
Large sample sizes; 
subjectivity minimized by 
carrying out study 
selection, 
data extraction, & quality 
assessment  
 
Weaknesses:  All studies 
had 
methodological 
weaknesses that could 
have biased results 
(inadequate allocation 
concealment); differences 
in interventions and 
outcomes 
limited the use of meta-
analysis to summarize 
results 
and explore heterogeneity 
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Golden et 
al., 2005 
Level II Randomized-controlled 
trial; (N = 931 in EPT 





patients 3 to 19 
weeks after 
treatment using 
urine samples for 
Chlamydia 
trachomatis and, 
for those who 
originally received 




LCx ligase chain 
reaction (Abbott 
Diagnostics) or 

















estimated with a 
generalized 
linear model 
with a binary 
outcome and 
log link and 
robust standard 
errors 
GC/CL infection significantly 
less common at follow-up 
among patients in EPT group 
than in standard-referral group 
(RR, 0.76; 95% CI, 0.59 to 
0.98). EPT of partners 
associated with a 73% 
reduction in presence of GC (3 
% vs. 11%, P=0.01), but only 
a 15% reduction in presence of 
CL infection at follow-up 
(11% vs. 13%, P=0.17).  
Strengths: 
Large sample size 
meeting power; 
randomization, high tool 
reliability and validity  
 
Weaknesses: loss to 




Level II Stepped-wedge, 
community level 
randomized- controlled 
trial; four intervention 
waves (6-8 mo each) 
randomly assigned to 
local health jurisdictions 
with purpose -To assess 
EPT effect as well as 
scalability of public 
health EPT intervention 
(23 jurisdictions; N = 
5,741) 
Promotion of EPT 
uptake – EPT 


















-2-tailed test  








1) EPT acceptance increase 
from 18.3% pre-intervention 
to 43.9% during intervention 
(p < 0.001)  
2) 92.6% patients receiving 
EPT reported compliance 
3) Chlamydia positivity 
decrease from 8.2% to 6.5% (p 
< 0.0001). Post hoc RR 
associated w/ 10% decrease in 
population-level infection 
measures.  
Strengths: large sample 
size, adequate power; 
RCT design; adequate 
time frame for evaluation 
of trends 
 
Weaknesses: inability to 
evaluate effect of state 
law changes mid-study 
increasing funding for 
EPT (possible 
confounding factor); 
inability to ensure no 
mixing of individuals in 
specific LHJ sample 
groups.  
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Level III Longitudinal study; 51 
state-level monthly 
morbidity rates (including 
D.C.) from national 
surveillance data with 
autoregressive time series 
model analysis; mixed 
model approach with 
analysis of fixed effects 
and random effects;  
(N= 26 states with EPT 
policies;  
Control = 25 states 
which lack EPT laws) 
Monthly state-level 
gonorrhea 
morbidity rates for 
males and females 
Jan 1995-Dec 
2014, no age 
restrictions; 
Autoregressive 
time series model, 
panel approach 
(higher variability 






















1) monthly variance in 
gonorrhea morbidity (both 
increasing/decreasing) existent 
in all states regardless of EPT 
laws 
2) fixed effects model 
showing 4 states had 
significant instant decrease of 
infection after EPT law (p < 
0.01) but 2 states had 
significant increase (p < 0.01) 
3) random effects model 
showing no significant 
differences in groups 
Strengths: large sample 
size; length of assessment 
adequate to monitor for 
trends; clear set-up for 
further research  
Weaknesses: study 
assessed only gonorrhea 
rates, limited by 
increasing resistance of 
bacteria through study 
period; limitation 
regarding surveillance 
data due to reliance on 
provider report of disease 
& inability to measure 
provider usage of EPT 
once legalized as well as 
patient adherence to 
treatment  
Hsii et al., 
2012 
Level III Cross-sectional study; 
anonymous online survey; 
289 responses from 
pediatric residents in 14 










analysis of PGY 
-21% reporting moderate or 
very familiar with EPT; 24% 
reporting having education on 
the practice (85% learned 
from direct patient care) 
Strengths: 
Results consistent with 
other studies regarding 
perceived barriers, 
provider knowledge; high 
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female, mean age 29.4 +/- 
2.7 years), postgraduate 
years 1,2, and 3 included 
with no exclusion criteria  
personal comfort 





point Likert scales 















sum test for 
ordinal 
variables.  
-inadequate understanding of 
EPT methods 
-52% reported using 1 type of 
EPT in practice, but 74% 
using EPT only “rarely” or 
“sometimes” 
-inadequate knowledge of 
clinical and state policy 
regarding EPT 
- perceived barriers including 
concern of adverse drug event, 
adherence, counselling, & 
unfamiliarity with policy 
 
participation with good 






biases due to survey 
nature of study design 
Schillinge
r et al., 
2016 
Level V Systematic review of 
published articles, data 
reports, and conference 
abstracts providing 
measures of 1) provider 
uptake of EPT  
2) patient delivery of EPT  
3) partner receipt of EPT 
and treatment; 42 














who are offered 







EPT when it is 
offered; “Partner 
receipt” defined as 
proportion of 




















1) 11 articles reporting percent 
of providers using EPT (range 
14%-73% for routine use) 
2) provider offer rate low 
(27% to 31%) as found in 3 
studies 
3) 3 sources reporting patient 
acceptance (38% to 70%) 
4) patient deliverance rate 
from 73%-100 from 4 
literature sources 
Strengths: 
Heterogeneous mix of 
study designs from RCTs 
to qualitative, good 
amount of data reviewed, 




Unpublished data used in 
attempt to collect most 
up-to-date data but 
weakens reliability of 
sources, variance of 
results for certain 
measures is high 
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least 1 partner 
treated by EPT 
Hodge et 
al., 2008 
Level V Qualitative descriptive 
study; identify legal 
provisions that affect a 
clinician’s ability to 
provide EPT through 
review of 3 areas of legal 
relevance: 1) medical 
licensing and liability 
2) public health and 
safety. 3) pharmaceutical 
practices 
-50 states + 2 jurisdiction  
-examined statutes, bills, 
administrative 
regulations, judicial cases 





Laws limited to 
those addressing, 
1) ability of 
authorized HCP to 
provide patient’s 
partner with STD 
treatment without 
physical exam; 2) 
judicial decisions 
regarding 
discipline for HCPs 
using EPT; 3) 
administrative 




4) legislative or 
prospective bills 
which provide 
insight into the 




guidelines that may 
support EPT; and 
6) prescription 
drug laws 
-No discussion of 
reliability/validity 
of tools 







jurisdiction in a 
comprehensive 






1) 12 jurisdictions where EPT 
is legal, 13 in which EPT is 
“probably legally prohibited”, 
and 28 where EPT is 
potentially allowable 
2) in those where EPT legality 
is uncertain, inconsistent or 
ambiguous laws may cause 
providers to hesitate use of 
this therapy (call for more 
explicit and direct legislation)  
3) CDC guidelines may 
effectively endorse EPT unless 
trumped by contrary statutory 
provision    
4) 88% boards perceive EPT 
as illegal or uncertain legality 
(barrier to use) 
Strengths: 
Establishing important 
parties in EPT 
legalization, no exclusion 
of states, per-reviewed, 
wide-range of inclusive 
and relevant search terms  
 
Weakness: due to article 
age and topic, some 
results from study may be 
outdated, no specific 
theoretical framework, no 
discussion of 
reliability/validity of tools 
used for measures, no 
statistical significance 
discussed due to nature of 
study 
EPT AND KY HEALTH POLICY ADVANCEMENT                                                       43 
Appendix B 
Logic Model for Project Implementation 
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Table 1 
KANPNM Member Demographics 
KANPNM Member Demographics 
n = 80 KANPNM Members 
(APRNs/graduate students) 
Demographic Variable n (%) 
Currently a KY Provider? 
     Yes 
     No 
 
57  (71.25) 
23  (28.75) 
Years of Experience: 
     <1 year 
     1-5 years 
     6-10 years 
     11-15 years 
     15+ years 
     N/A (students) 
 
7  (8.75) 
23  (28.75) 
9  (11.25) 
8  (10.00) 
23  (28.75) 
10  (12.50) 
Highest Degree Held: 
     BSN 
     MSN 
     DNP 
     PhD 
 
13  (16.46) 
45  (56.96) 
18 (22.78) 
3  (3.80) 
Currently Treating STIs? 
     Yes 
     No 
 
53  (66.25) 
27  (33.75) 
Number of Monthly Patient 
Encounters for STI 
Screening/Treatment: 
    1-5 
    6-10 
    11-15 
    15+ 




19  (25.00) 
16  (21.05) 
7  (9.21) 
8  (10.53) 
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Table 2 














Survey Question n (%) n (%) n (%) n (%) n (%) 
Knowledgeable of EPT 











Current STI Treatment 











Current STI Treatment 











EPT a Beneficial 












Would use EPT in 












Would Support EPT 
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